76 related articles for article (PubMed ID: 7502745)
1. Neutralization of HIV infection by serum IgA antibodies.
Kozlowski P; Buckheit RW; Jackson S
Adv Exp Med Biol; 1995; 371B():1027-30. PubMed ID: 7502745
[No Abstract] [Full Text] [Related]
2. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
3. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.
Kozlowski PA; Chen D; Eldridge JH; Jackson S
AIDS Res Hum Retroviruses; 1994 Jul; 10(7):813-22. PubMed ID: 7986587
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
[TBL] [Abstract][Full Text] [Related]
5. Serum and salivary antibodies to a mycobacterial 65-kDa stress protein are elevated in HIV-positive patients and modified by oral candidiasis.
Coogan MM; Challacombe SJ
Oral Microbiol Immunol; 2000 Oct; 15(5):284-9. PubMed ID: 11154418
[TBL] [Abstract][Full Text] [Related]
6. IgA and IgG antibodies to distinct serotypes of Mycobacterium avium in HIV seropositivity and AIDS.
Hernandez-Munoz HE; Stanford JL
J Med Microbiol; 1996 Mar; 44(3):165-9. PubMed ID: 8636932
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.
Burrer R; Salmon-Ceron D; Richert S; Pancino G; Spiridon G; Haessig S; Roques V; Barre-Sinoussi F; Aubertin AM; Moog C
J Virol; 2001 Jun; 75(11):5421-4. PubMed ID: 11333928
[TBL] [Abstract][Full Text] [Related]
8. Serum IgA-mediated neutralization of HIV type 1.
Burnett PR; VanCott TC; Polonis VR; Redfield RR; Birx DL
J Immunol; 1994 May; 152(9):4642-8. PubMed ID: 8157978
[TBL] [Abstract][Full Text] [Related]
9. Is there IgA of gut mucosal origin in the serum of HIV1 infected patients?
Quesnel A; Moja P; Lucht F; Touraine JL; Pozzetto B; Genin C
Gut; 1994 Jun; 35(6):803-8. PubMed ID: 7517378
[TBL] [Abstract][Full Text] [Related]
10. IgA-anti-Fab autoantibodies and disease progression in AIDS.
Süsal C; Daniel V; Doerr C; Zimmermann R; Huth-Kühne A; Opelz G
Immunol Lett; 1993 Apr; 36(1):27-30. PubMed ID: 8102124
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
12. [Apoptosis in HIV infection].
Maroto Vela Mdel C
An R Acad Nac Med (Madr); 1994; 111(2):289-311; discussion 311-6. PubMed ID: 7810838
[No Abstract] [Full Text] [Related]
13. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG.
Kozlowski PA; Black KP; Shen L; Jackson S
J Immunol; 1995 Jun; 154(11):6163-73. PubMed ID: 7751656
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum immunoglobulin A antibodies to pol gene products during HIV-1 infection.
Quesnel A; Pozzetto B; Moja P; Grattard F; Lucht FR; Touraine JL; Gaudin OG; Genin C
Clin Exp Immunol; 1993 Feb; 91(2):237-40. PubMed ID: 8094040
[TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
[TBL] [Abstract][Full Text] [Related]
16. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus 1: predominance of a group-specific neutralizing epitope that persists despite genetic variation.
Dis Markers; 1990; 8(2):105-7. PubMed ID: 1696869
[No Abstract] [Full Text] [Related]
19. Multispot HIV-1/HIV-2 Rapid Test: advantages over other rapid HIV tests.
O'Conell RJ; Peel SA
Expert Rev Mol Diagn; 2007 Sep; 7(5):499-505. PubMed ID: 17892358
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
